Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial — Masafumi Ikeda (2017) | RDL Network
Masatoshi Kudo, Guohong Han, Richard S. Finn, Ronnie T.P. Poon, Jean–Frédéric Blanc, Lünan Yan, Jijin Yang, Ligong Lu, Won Young Tak, Xiaoping Yu, Joon-Hyeok Lee, Shi‐Ming Lin, Changping Wu, Tawesak Tanwandee, Guoliang Shao, Ian Walters, Christine Dela Cruz, Valerie Poulart, Jianhua Wang
Michael Buckstein, Edward Kim, Umut Özbek, Parissa Tabrizian, Ganesh Gunasekaran, Marcelo Facciuto, Kenneth E. Rosenzweig, Josep M. Llovet, Myron Schwartz
International Journal of Radiation Oncology*Biology*Physics
Discussion(0)
No comments yet. Be the first to comment.